Beam Therapeutics (BEAM) Payables (2019 - 2025)
Historic Payables for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to $9.5 million.
- Beam Therapeutics' Payables rose 15039.35% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year increase of 15039.35%. This contributed to the annual value of $3.9 million for FY2024, which is 13939.39% up from last year.
- Beam Therapeutics' Payables amounted to $9.5 million in Q3 2025, which was up 15039.35% from $10.6 million recorded in Q2 2025.
- Beam Therapeutics' 5-year Payables high stood at $14.1 million for Q1 2023, and its period low was $1.6 million during Q4 2023.
- For the 5-year period, Beam Therapeutics' Payables averaged around $6.8 million, with its median value being $7.1 million (2022).
- Per our database at Business Quant, Beam Therapeutics' Payables crashed by 8209.1% in 2023 and then soared by 17594.98% in 2025.
- Over the past 5 years, Beam Therapeutics' Payables (Quarter) stood at $7.5 million in 2021, then increased by 20.81% to $9.0 million in 2022, then plummeted by 82.09% to $1.6 million in 2023, then surged by 139.39% to $3.9 million in 2024, then skyrocketed by 146.58% to $9.5 million in 2025.
- Its last three reported values are $9.5 million in Q3 2025, $10.6 million for Q2 2025, and $7.7 million during Q1 2025.